202 related articles for article (PubMed ID: 1552048)
21. Skin carcinomas and treatment with photochemotherapy (PUVA).
Lindskov R
Acta Derm Venereol; 1983; 63(3):223-6. PubMed ID: 6192635
[TBL] [Abstract][Full Text] [Related]
22. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis.
Stern RS; Lunder EJ
Arch Dermatol; 1998 Dec; 134(12):1582-5. PubMed ID: 9875197
[TBL] [Abstract][Full Text] [Related]
23. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
Katz KA; Marcil I; Stern RS
J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
[TBL] [Abstract][Full Text] [Related]
24. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
Stern RS; Nichols KT; Väkevä LH
N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study.
Cox NH; Jones SK; Downey DJ; Tuyp EJ; Jay JL; Moseley H; Mackie RM
Br J Dermatol; 1987 Feb; 116(2):145-52. PubMed ID: 3828211
[TBL] [Abstract][Full Text] [Related]
26. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA.
Hannuksela A; Pukkala E; Hannuksela M; Karvonen J
J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):685-9. PubMed ID: 8912561
[TBL] [Abstract][Full Text] [Related]
27. PUVA keratosis. A clinical and histopathologic entity associated with an increased risk of nonmelanoma skin cancer.
van Praag MC; Bavinck JN; Bergman W; Rosendaal FR; Mommaas AM; Bruynzeel I; Scheffer E; Vermeer BJ; Bruijn JA
J Am Acad Dermatol; 1993 Mar; 28(3):412-7. PubMed ID: 8445056
[TBL] [Abstract][Full Text] [Related]
28. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
Gasparro FP
Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
[TBL] [Abstract][Full Text] [Related]
29. PUVA treatment and skin cancer: A follow-up study.
Lassus A; Reunala T; Idänpää-Heikkilä J; Juvakoski T; Salo O
Acta Derm Venereol; 1981; 61(2):141-5. PubMed ID: 6165190
[TBL] [Abstract][Full Text] [Related]
30. Risk of cutaneous carcinoma in psoriatic patients treated with PUVA.
Eskelinen A; Halme K; Lassus A; Idänpään-Heikkilä J
Photodermatol; 1985 Feb; 2(1):10-4. PubMed ID: 3982991
[TBL] [Abstract][Full Text] [Related]
31. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
Forman AB; Roenigk HH; Caro WA; Magid ML
Arch Dermatol; 1989 Apr; 125(4):515-9. PubMed ID: 2649011
[TBL] [Abstract][Full Text] [Related]
32. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis.
Hannuksela-Svahn A; Sigurgeirsson B; Pukkala E; Lindelöf B; Berne B; Hannuksela M; Poikolainen K; Karvonen J
Br J Dermatol; 1999 Sep; 141(3):497-501. PubMed ID: 10583054
[TBL] [Abstract][Full Text] [Related]
33. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
Lim JL; Stern RS
J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190
[TBL] [Abstract][Full Text] [Related]
34. The risk of melanoma in association with long-term exposure to PUVA.
Stern RS;
J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
[TBL] [Abstract][Full Text] [Related]
35. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
[TBL] [Abstract][Full Text] [Related]
36. p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms.
Proby CM; du Peloux Menagé H; McGregor JM; Hobbs C; Norris PG; Smith N; Hawk JL; McKee PH
J Cutan Pathol; 1993 Oct; 20(5):435-41. PubMed ID: 8300928
[TBL] [Abstract][Full Text] [Related]
37. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
38. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance.
van de Kerkhof PC; de Rooij MJ
Br J Dermatol; 1997 Feb; 136(2):275-8. PubMed ID: 9068750
[TBL] [Abstract][Full Text] [Related]
39. Incidence of skin cancer in Japanese psoriatic patients treated with either methoxsalen phototherapy, Goeckerman regimen, or both therapies. A 10-year follow-up study.
Torinuki W; Tagami H
J Am Acad Dermatol; 1988 Jun; 18(6):1278-81. PubMed ID: 3385042
[TBL] [Abstract][Full Text] [Related]
40. Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy.
Maiorino A; De Simone C; Perino F; Caldarola G; Peris K
J Dermatolog Treat; 2016 Oct; 27(5):443-7. PubMed ID: 26822468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
